Table 1.

Patient demographics and baseline characteristics.

	N = 18
Median (range) age, years	73 (22–79)
Male/female, n	10/8
ECOG performance status, n (%)
0–1	11 (61.1)
2–3	7 (38.9)
Disease status, n (%)
Refractory	4 (22.2)
Relapsed	14 (77.8)
Median of previously therapy lines (n)
Refractory	1.5 (1 n = 2, 2 n = 2)
Relapsed	2.5 (1 n = 5, 2 n = 2, ≥3 n = 7)
Previously allogeneic HSCT, n	8
Cytogenetics, n (%)
Normal	3 (16.7)
Unfavorable	13 (72.2)
Missing	2 (11.1)
Baseline peripheral blood / bone marrow (range)
Median (range) WBC count, G/L	3.51 (1.27–24.44)
Median (range) peripheral blasts, %	15 (0–89)
Median (range) bone marrow blasts, %	52.5 (10–100)

ECOG Eastern cooperative oncology group, HSCT hematopoietic stem cell transplantation, WBC white blood cells.